Context Capital Management, LLC has filed its 13F form on May 05, 2025 for Q1 2025 where it was disclosed a total value porftolio of $194,000 distributed in 208 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Denali Cap Acquisition Corp Wt with a value of $36K, Global Blockchain Acq Corp Rt with a value of $28K, Cartica Acquisition Corp with a value of $26K, Bannix Acquisition Corp. with a value of $25K, and Aimfinity Investment Corp. I with a value of $16K.
Examining the 13F form we can see an decrease of $128K in the current position value, from $322K to 194K .
Below you can find more details about Context Capital Management, LLC portfolio as well as his latest detailed transactions.
Financial Services: $110,000
ETFs: $41,000
Healthcare: $6,000
Basic Materials: $0
Stock
Market Cap.
Holding Value (Reported)
# of Shares.
Last Trade
Trade History
Mirum Pharmaceuticals Inc
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 5.03%
-
$0
0.0% of portfolio
-
Q1 2025
New
Microchip Technology Inc.
-
$0
0.0% of portfolio
-
Q1 2025
New
-
$0
0.0% of portfolio
-
Q2 2024
Added 52.1%
Marriott Vacations Worldwide
-
$0
0.0% of portfolio
-
Q1 2025
New
-
$0
0.0% of portfolio
-
Q1 2025
Added 8.29%
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 14.51%
-
$0
0.0% of portfolio
-
Q1 2025
Added 27.7%
-
$0
0.0% of portfolio
-
Q4 2024
New
-
$0
0.0% of portfolio
-
Q4 2024
Added 10.0%
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 0.9%
-
$0
0.0% of portfolio
-
Q1 2025
Added 20.43%
-
$0
0.0% of portfolio
-
Q1 2025
New
-
$0
0.0% of portfolio
-
Q1 2025
Added 38.97%
Two Harbors Inventment Corpo
-
$0
0.0% of portfolio
-
Q1 2024
Reduced 99.9%
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 29.22%
-
$0
0.0% of portfolio
-
Q4 2024
New
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 31.88%
-
$0
0.0% of portfolio
-
Q2 2024
Reduced 1.02%
-
$0
0.0% of portfolio
-
Q1 2025
Added 12.16%
-
$0
0.0% of portfolio
-
Q4 2024
New
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 82.37%
-
$0
0.0% of portfolio
-
Q1 2025
Added 125.0%
-
$0
0.0% of portfolio
-
Q1 2024
New
-
$0
0.0% of portfolio
-
Q1 2024
Reduced 99.9%
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 23.57%
-
$0
0.0% of portfolio
-
Q1 2025
New
-
$0
0.0% of portfolio
-
Q2 2024
Reduced 5.15%
-
$0
0.0% of portfolio
-
Q1 2025
Added 7.5%
-
$0
0.0% of portfolio
-
Q1 2025
Added 171.98%
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 11.42%
-
$0
0.0% of portfolio
-
Q1 2025
Added 1,073.33%
-
$0
0.0% of portfolio
-
Q1 2025
Added 2,628.27%
-
$0
0.0% of portfolio
-
Q1 2025
New
-
$0
0.0% of portfolio
-
Q1 2025
New
-
$0
0.0% of portfolio
-
Q1 2025
New
Silexion Therapeutics Corp
-
$0
0.0% of portfolio
-
Q4 2024
Reduced 17.76%
-
$0
0.0% of portfolio
-
Q4 2024
New
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 84.39%
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 66.67%
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 18.54%
-
$0
0.0% of portfolio
-
Q1 2025
New
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 15.06%
-
$0
0.0% of portfolio
-
Q1 2025
Added 24.49%
-
$0
0.0% of portfolio
-
Q4 2024
Reduced 3.75%
-
$0
0.0% of portfolio
-
Q1 2025
New
-
$0
0.0% of portfolio
-
Q3 2024
New
-
$0
0.0% of portfolio
-
Q3 2024
New
-
$0
0.0% of portfolio
-
Q1 2025
New
-
$0
0.0% of portfolio
-
Q1 2025
Added 12.98%